AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

Clinical trial NCT05191667 · SUSPENDED

Trial details

NCT number: NCT05191667
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2022-01-18
Primary completion: 2025-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.